These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6173406)

  • 21. [Plasminogen activator: human granulocyte "kininogenase"; inhibition by an acid-stable inhibitor from blood plasma].
    Ogloblina OG; Platonova LV; Paskhina TS
    Dokl Akad Nauk SSSR; 1982; 265(4):982-5. PubMed ID: 6813087
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative studies on human activators of plasminogen.
    Mackie M; Booth NA; Bennett B
    Br J Haematol; 1981 Jan; 47(1):77-90. PubMed ID: 6449216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma.
    Wiman B; Lindahl T; Almqvist A
    Thromb Haemost; 1988 Jun; 59(3):392-5. PubMed ID: 3142076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stability of tissue plasminogen activator].
    Liutova LV; Andreenko GV; Shimonaeva EE
    Vopr Med Khim; 1985; 31(1):97-9. PubMed ID: 3920826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activator (PA) in Guerin epithelioma. Additional PA inhibitor in plasma of rats bearing the epithelioma.
    Tomasiuk R; Mirowski M; Wierzbicki R
    Neoplasma; 1990; 37(5):511-9. PubMed ID: 2146518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possibilities of early diagnosis of thromboembolic complications in myocardial infarct by means of biochemical methods].
    Andreenko GV; Bessolitsyna LA; Sargin KE
    Kardiologiia; 1977 Jan; 17(1):98-103. PubMed ID: 140260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet release protein which inhibits plasminogen activators.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1985 Jul; 38(7):825-30. PubMed ID: 3926830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identity of kininogenase and plasminogen activators in human granulocytes].
    Ogloblina OG; Platonova LV; Paskhina TS; Martynov VF; Sorochinskaia EI
    Biokhimiia; 1984 Feb; 49(2):302-9. PubMed ID: 6424731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
    Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
    Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemostasiology. Antifibrinolytic mechanisms of the liver].
    Jedrychowski A; Parbhoo SP; Hillenbrand P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1139-42. PubMed ID: 417485
    [No Abstract]   [Full Text] [Related]  

  • 32. [The stimulation of fibrinolysis during cholinergic vasodilating reactions].
    Bashkov GV; Sergeev IIu; Medvedeva NA; Makarov VA
    Fiziol Zh (1978); 1990; 36(4):3-8. PubMed ID: 2146171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of ethanol and acetaldehyde on fibrinolytic system (examinations in vitro).
    Skrzydlewska E; Worowski K
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():163-73. PubMed ID: 6242841
    [No Abstract]   [Full Text] [Related]  

  • 34. Properties of a partially purified preparation of a circulating plasminogen activator.
    Ogston D; Bennett B; Mackie M
    Thromb Res; 1976 Mar; 8(3):275-84. PubMed ID: 131386
    [No Abstract]   [Full Text] [Related]  

  • 35. Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.
    Ny T; Bjersing L; Hsueh AJ; Loskutoff DJ
    Endocrinology; 1985 Apr; 116(4):1666-8. PubMed ID: 3918858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the fibrinolytic system in human fetuses and in pregnant women.
    Reverdiau-Moalic P; Gruel Y; Delahousse B; Rupin A; Huart MC; Body G; Leroy J
    Thromb Res; 1991 Mar; 61(5-6):489-99. PubMed ID: 2028451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fibrinolytic system in patients with nephrotic syndrome].
    Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
    Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behçet's disease: a vascular function study by the venostasis test and DDAVP infusion].
    Le Roux G; Guillevin L; Casassus P; Gayraud M; Limon S
    Rev Med Interne; 1985 Mar; 6(2):111-5. PubMed ID: 3923585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
    Booth NA; Anderson JA; Bennett B
    Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on fibrinolytic activity in Behçet's disease. 3. An approach by affinity chromatography (author's transl)].
    Saito K
    Nippon Ganka Gakkai Zasshi; 1973 Sep; 77(9):1443-51. PubMed ID: 4271707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.